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Purpose: In an effort to generate inducible RPE-speciﬁc Cre mice using a 3.0-kb human vitelliform mac-
ular dystrophy-2 (VMD2) promoter, we identiﬁed a mouse line with unanticipated Cre activity in the
neural retina, including Müller glial cells. Müller cells play important roles in the function and mainte-
nance of the retina, and this mouse line would be potentially useful for conditional gene targeting in
Müller glia. We therefore characterized the timing, inducibility, and cell speciﬁcity of Cre expression,
as well as Müller cell-speciﬁc efﬁciency of Cre-mediated recombination in this mouse line.
Methods: Transgenic mice carrying cassettes of human PVMD2-rtTA and TRE-cre were generated. Cre
expression was characterized using a Cre-activatable lacZ reporter mouse line (R26R) and a ﬂoxed inter-
leukin six signal transducing receptor (gp130) mouse line.
Results: b-Galactosidase (b-gal) assay and immunohistochemical analysis of VMD2-cre/R26R double trans-
genic mice indicated that Cre activity was detected in cells located in the inner nuclear layer, with promi-
nent expression of b-gal inMüller cells. Cre activitywas also detected in photoreceptors in the outer nuclear
layer. PCR analysis demonstrated that Cre-mediated recombination initiated by embryonic day 15. Immu-
nohistochemical analysis indicated that Cre-mediated deletion of ﬂoxed gp130 gene occurred in 52% of the
retinal Müller cells. Retinal function and morphology were normal in 10-month-old VMD2-cremice.
Conclusion: We generated a transgenic cremouse that is useful to study gene activation and inactivation in
retinal Müller cells.
 2009 Elsevier Ltd. All rights reserved.1. Introduction
One of the recent breakthroughs in molecular medicine is the
use of gene targeting to elucidate protein function in mice. How-
ever, disruption of an essential gene expressed in multiple tissues
or cell-types often causes embryonic or neonatal lethality, obscur-
ing its role in a target cell or in the adult (Ferrara et al., 1996; Rucker
et al., 2000). The Cre/lox-based conditional gene knockout strategy
has become a method of choice to circumvent this problem. Cre
recombinase of bacteriophage P1 catalyzes site-speciﬁc DNA
recombination both intra- and intermolecularly between target
34-bp loxP sites (Sauer & Henderson, 1988). Efﬁcient Cre-mediated
excision of DNA between directly repeated loxP sites is the molecu-
lar basis for conditional gene knockout in mice (for review, see Le &
Sauer, 2000). With a goal to obtain inducible RPE-speciﬁc Cre mice,
we recently generated transgenic mice expressing Cre recombinase
under the control of a 3.0-kb human VMD2 (vitelliform macularll rights reserved.
Blvd., BSEB 302G, Oklahomadystrophy; VMD) promoter directed reverse tetracycline-inducible
gene expression system (Le et al., 2008). The human VMD2 gene is
associated with Best disease and is thought to be preferentially ex-
pressed in the RPE (Marquardt et al., 1998; Petrukhin et al., 1998).
To our surprise, approximately half of the Cre-expressing trans-
genic lines demonstrated Cre activity in the neural retina, with
prominent Cre-activated b-galactosidase (b-gal) staining in Müller
cells. Müller cells are the principle supporting glial cells in the neu-
ral retina and they participate inmany essential functions including
homeostasis, neural protection, angiogenesis, and perhaps neural
regeneration (for review, see (Bringmann et al., 2006)). Therefore,
this transgenic mouse line may have important utility for studies
related to gene function in Müller cells. This report describes the
characterization of this mouse line.
2. Materials and methods
2.1. Animals care and treatment
All animal procedures followed the guidelines of the ARVO
statement for the ‘‘Use of Animals in Ophthalmic and Vision
Fig. 1. Schematic drawing of transgenes in recombinant plasmids pLE119 and
pLE116. PVMD2, promoter of human VMD2 gene; rtTA, structure gene for reverse-tet
system transactivator; SV40 A(n), simian virus 40 polyadenylation signal; PhCMV,
immediate early promoter of human cytomegalovirus; cre, structure for Cre; MT-I
A(n), mouse metallothionein polyadenylation signal. XhoI and HindIII are restriction
enzymes that were used to release the transgenes from the vectors.
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Use Committees at the University of Oklahoma Health Sciences
Center, the Dean A. McGee Eye Institute, and the Oklahoma Medi-
cal Research Foundation. Doxycycline was administered through
the drinking water of pregnant mothers at a concentration of
0.5 mg/mL in 5% sucrose from embryonic day 15 to postnatal day 2.
Transgenicmiceweregeneratedasdescribedpreviously (Leet al.,
2008).Mice carrying theﬂoxed gp130gene (gp130f/f)were a gift from
Dr. W. Müller of University of Cologne, Germany (Betz et al., 1998).
PCR analysis for the cre transgene was carried out with primers a
(50-AGG TGT AGA GAA GGC ACT TAG C-30) and b (50-CTA ATC GCC
ATC TTC CAG CAG G-30) to detect a 411-bp product. PCR analysis
for the rtTA transgene was carried out using primers c (50-CGG CCT
TGA ATT GAT CAT ATG CGG-30) and d (50-TCA AAC TCG AAG TCG
GCC ATA TCC-30) to detect a 398-bp product. PCR diagnosis for the
Cre-activatable lacZ reporter gene in R26Rmicewas carried outwith
primers e (50-GAG TTG CGT GAC TAC CTA CGG-30) and f (50-GGC TTC
ATCCACCACATACAGG-30) to detect a 495-bpproduct. PCR analysis
forCre-mediateddeletionof theﬂoxedgp130genewasperformedas
described previously (Yao, Yokota, Xia, Kincade, & McEver, 2005),
using primers g (50-GAT GAA GGT GGG AAA GAT GGG CCG GAA
TTC-30) and h (50-GGA AGG ATC AGG AAC ATT AGG CCA GAT GTG-
30) to detect a 600-bp product.
2.2. b-Galactosidase assay
The b-gal assay on retinal whole mounts and retinal sections
was performed as described previously (Le et al., 2006, 2008). Li-
quid b-gal assay was carried out according to a previous procedure
with some modiﬁcation (Le et al., 2008). Eyes were enucleated and
stored at 80 C immediately. On the day of assay, the frozen ret-
ina was homogenized in 200 ll of Z-buffer containing 50 mM
sodium phosphate buffer (pH 7.0), 10 mM KCl, and 1 mM MgSO4.
The cell debris was removed by centrifugation (10,000 rpm for
10 min on a bench top centrifuge), 106 ll of the supernatant was
mixed with 21 ll of 2-nitrophenyl b-D-galactopyronoside (ONPG,
4 mg/ml in water) and incubated at 30 C for 30 min. The reaction
was stopped by adding 53 ll of 1 M Na2CO3 to the reaction mixture
and the optical density was measured at 420 and 550 nm.
Protein concentrations were measured with a BCA protein assay
kit (Pierce, Rockford, IL). b-Gal activity was calculated as 1000 
[OD420  (1.75  D550)]/time  protein (mg) (Rajala, McClellan,
Chan, Tsiokas, & Anderson, 2004). Relative activity was the per-
centage of speciﬁc activity compared with that from VMD2-cre/
R26R mice under a non-induced condition.
2.3. Immunoblotting and immunohistochemistry
Immunoblotting for Cre was performed according to a previous
method (Le et al., 2006), using an anti-Cre antibody (Novagen).
Immunohistochemistry (IHC) was performed as described previ-
ously (Ueki, Wang, Chollangi, & Ash, 2008). Brieﬂy, the cornea
and lens were removed and the eye cups were ﬁxed with 4% para-
formaldehyde in PBS for 30 min. Eye cups were then cryoprotected
with a series of sucrose solution (10–30%) and cross-sections of the
retina were obtained using a cryostat. Retinal cross-sections were
immunostained using anti-b-gal antibody (#7-063100, 5 Prime-3
Prime, Boulder, CO; 1:100 dilution), anti-pSTAT3 antibody
(#9131, Cell Signaling Technology, Danvers, MA; 1:50 dilution)
and anti-glutamine synthetase (GS) antibody (#MAB302; Chem-
icon, Temecula, CA; 1:1000 dilution). To detect gp130 activation,
VMD2-cre/gp130f/f mice were injected intravitreally with a gp130
ligand, leukemia inhibitory factor (LIF), as described previously
(Ueki et al., 2008). Eyes were collected 30 min after the injection.
STAT3 phosphorylation was detected with IHC. Confocal imaging
was performed using a FluoView FV500 confocal laser scanningmicroscope (Olympus). Imaging and microscope settings were
identical in all samples. For quantiﬁcation, sections were co-
stained for pSTAT3 and GS. pSTAT3-postive and GS-positive cells
were counted in a 100 lm stretch of the inner nuclear layer in
images obtained with a confocal microscope (10 mm stack). The
frequency of Cre-mediated recombination was calculated based
on the number of pSTAT3-positive and GS-positive Müller cell nu-
clei relative to the total GS-positive Müller cell nuclei.
2.4. Electroretinography and retinal morphology
For scotopic and photopic electroretinography (ERG), mice were
dark adapted overnight. The ERG was performed with a UTAS-E
3000 ERG system (LKC technologies, Inc., Gaithersburg, MD),
according to a previously method (Le et al., 2004; Quiambao
et al., 1997; Xu et al., 2000). Retinal morphology was examined
in hematoxylin and eosin (H & E) stained sections, as described
previously (Le et al., 2006).
3. Results
3.1. Generation of Cre-expressing transgenic mice
In a previous study, we used a 3.0-kb promoter of the human
VMD2 gene to generate tetracycline-inducible RPE-speciﬁc Cre
mice (Le et al., 2008). The human VMD2 gene is thought to be ex-
pressed preferentially in the RPE (Marquardt et al., 1998; Petrukhin
et al., 1998). The transgenic mice were generated using a so-called
tet-on system to control Cre expression (Gossen et al., 1995). The
VMD2 promoter (PVMD2) was used to direct the expression of the
tetracycline-inducible transactivator gene rtTA. The rtTA should
then drive the expression of the tetO controlled cre gene in the
presence of doxycycline (Fig. 1). Our cre transgene included a
translationally optimized cre, and the intron-containing mouse
metallothionein (MT-I) polyadenylation signal. This expression
vector has a proven record of success in transgenic studies (Le
et al., 2004, 2006). The transgenic DNA fragments, the PVMD2-rtTA
and tetO-PhCMV-cre, were co-injected into zygotes, and were co-
integrated into a single chromosome in all transgenic founders,
as demonstrated in the PCR analysis of segregation patterns for
more then 10 generations (data not shown). Co-integration of both
transgenes onto a single chromosome provides a distinct advan-
tage over separate transgene integration and it will reduce the re-
quired breeding for future downstream studies in conditional gene
knockout studies. All germline-transmitted mice appeared to be
normal in size, morphology, and behavior. Five of the 10 Cre-
expressing transgenic lines demonstrated different levels of Cre
activity in the retinal Müller cells. One of them showed substantial
Cre-activated b-gal reporter expression in the Müller cells and was
characterized further (see discussion below). This line of VMD2-cre
mice were also bred with ﬂoxed gp130 (gp130ff) mice (Betz et al.,
1998). Neither the VMD2-cre/R26R mice nor the VMD2-cre/gp130ff
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were suitable for downstream characterization.
3.2. Analysis of inducible and developmental Cre activity
To determine the inducibility of Cre expression in the VMD2-cre
mice, we utilized the Cre-activatable b-gal reporter (R26R) mice. In
R26R mice b-gal can be activated after Cre-mediated excision of a
ﬂoxed transcriptional ‘‘STOP” DNA segment (Soriano, 1999). Cre
expression was analyzed quantitatively through indirect measure-
ment of Cre-activated b-gal enzyme activity using retinal homoge-
nates of F1 VMD2-cre/R26R mice. To determine the basal level of
Cre expression under a non-induced condition, the pregnant moth-
ers were placed on an autoclaved diet (LabDiet 5010; Statewide
Supply, Oklahoma City, OK) that demonstrated a lower basal level
of Cre expression in a previous study (Le et al., 2008), presumably
due to heat-inactivation of the trace amount of tetracycline
derivatives in the diet. To induce Cre expression in the pups, the
pregnant females were then supplied with doxcycyline (Dox), a
tetracycline derivative, in drinking water from embryonic day 15
(E15) to postnatal day 10 (P10). Protein homogenates from P15
retina were used in the b-gal assay. Compared with the b-gal-spe-
ciﬁc activity produced by non-transgenic controls, signiﬁcantly
more (82.5  2.4%) of b-gal activity was expressed in the retina
of VMD2-cre/R26R mice under non-induced condition (Fig. 2A),
indicating that the tetracycline gene expression system was not
tightly controlled. The induced VMD2-cre/R26Rmice demonstrated
40.0  15.0% of more b-gal-speciﬁc activity, compared with that in
non-induced mice (Fig. 2A). This result suggests that the tetracy-Fig. 2. Analysis of Cre expression in the retina of VMD2-cre/R26Rmice. (A) In vivo inductio
homogenates from VMD2-cre/R26Rmice. Induction was carried out from E15 to P10 and b
: p < 0.05. Signiﬁcant amount of b-gal was expressed without induction. However, the ind
analysis of Cre-mediated recombination in the retina of the VMD2-cre/gp130f/f mice. (C)
mice. Cre function was detected in the retina at embryonic day 15 (E15). However, Cre p
Fig. 3. Localization of Cre expression in VMD2-cre/R26Rmice with b-gal staining assay. (A
staining in a P5 retinal section. (D) Localization of Cre function in Müller cells in a retin
pattern in Müller cells. Scale bar equals to 100 lm. Outer nuclear layer (onl) and inner n
Müller cells.cline gene expression system was leaky and there was limited
inducibility in this mouse line.
To determine the time-course of Cre-mediated recombination,
we performed PCR analysis diagnostic for Cre-mediated excision
at gp130 locus. Cre-mediated recombination in the VMD2-cre/
gp130f/f mice was detected in mice as early as embryonic day 15
(E15) (Fig. 2B), suggesting that Cre expression was initiated during
embryonic development and before the development of the retinal
Müller cells. To estimate the level of Cre expression, immunohisto-
chemistry (IHC) and immunoblotting were performed using an
anti-Cre antibody that had a proven record of success in the char-
acterization of other retinal cell-speciﬁc Cre mice (Le et al., 2004,
2006). However, no positively stained cells in retinal sections (data
not shown) or speciﬁc immunoblotting signals from retinal
homogenates were identiﬁed in mice from birth to two weeks of
age (Fig. 2C). These results are not unexpected, since Cre activity
was detected as early as E15. In addition, a productive Cre-medi-
ated recombination requires only eight copies of Cre recombinase
in a particular cell (Guo, Gopaul, & van Duyne, 1997), and there-
fore, the minimal level of protein required for a productive
Cre-mediated recombination is likely much lower than the thresh-
old of detecting Cre expression by IHC and immunoblotting.
3.3. Localization and efﬁciency of Cre expression
To localize Cre function in the retina, we performed a b-gal stain-
ing assay on retinal sections from VMD2-cre/R26R mice. Cre func-
tion was detected in neural retina, with clearly identiﬁable
expression pattern in the retinal Müller cells (Fig. 3). We thenn of Cre-activated b-gal expression bymeasuring relatively speciﬁc activity in retinal
-gal activity assay was carried out at P15. Error bars: standard errors. : p < 0.001.
uced VMD2-cre/R26Rmice demonstrated 40.0  15.0% of more b-gal activity. (B) PCR
Western blot analysis of Cre expression in the postnatal retina of VMD2-cre/gp130f/f
rotein in the retina was undetectable postnatally with Western blot.
and B) Overall b-gal staining pattern in retinal ﬂat-mounts (A) sections (B). (C) b-Gal
a section after a brief (3 h) b-gal staining. Arrows point to distinct Cre expression
uclear layer (inl) are labeled. Cre function was localized to neural retina, including
618 Y. Ueki et al. / Vision Research 49 (2009) 615–621performed IHC on retinal sections using antibodies against b-gal
and glutamate synthetase (GS), a Müller cell-speciﬁc marker.
b-Gal was detected in the retinal Müller cells and unknown inner
nuclear layer neurons. b-Gal was also observed in some photore-
ceptors (Fig. 4). The activation of b-gal in VMD2-cre+/R26Rmice only
requires Cre-mediated excision of a single allele, andmay over-rep-
resent the efﬁciency of Cre-mediated deletion of two alleles in con-
ditional gene inactivation studies. To determine the efﬁciency of
Cre-mediated gene excision in Müller cells, we used mice homozy-
gous for the ﬂoxed gp130 gene. Activation of STAT3 by tyrosineFig. 4. Localization of Cre expression in six-week-old VMD2-cre/R26R mice with IYC. (A
(E–H) and (I–L) high magniﬁcation images. Nuclei were counterstained with DAPI. Outer
(is), outer plexiform layer (opl), and inner plexiform layer (ipl) are labeled. Scale bars eq
Müller cell marker (arrows). Some photoreceptors and un-identiﬁed INL neurons werephosphorylation is a direct signaling event downstream of gp130
in all retinal cells, includingMüller cells (Ueki et al., 2008). To quan-
tify deletion of ﬂoxed gp130we took an advantage of STAT3 activa-
tion in the presence of leukemia inhibitory factor (LIF). Injection of
LIF induced the activation of STAT3 in all Müller cells in VMD2-cre/
gp130f/f mice (Fig. 5A–C). In contrast, STAT3 was not activated in
52.1  2.6% of Müller cells in VMD2-cre+/gp130f/f mice (Fig. 5D–F).
Since STAT3 activation by LIF requires gp130, this result indicates
that the frequency of Cre-mediated excision of two ﬂoxed gp130
alleles occurred in 52.1% of Müller cells (Fig. 5G).–D) Representative IHC image of Cre-activated b-gal expression in retinal section.
nuclear layer (onl), inner nuclear layer (inl), ganglion cell layer (gcl), inner segment
ual to 25 lm. Cre-activated b-gal was colocalized with glutamate synthetase (GS), a
also positive for Cre-activated b-gal (arrowheads).
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Previously studies demonstrated that mouse opsin promoter di-
rected over-expression of Cre in rods results in photoreceptor
degeneration (Jimeno et al., 2006; Le et al., 2006). Although the
underline mechanism is unclear, over-expression of Cre can cause
undesired chromosomal rearrangement in mammals (Loonstra
et al., 2001; Schmidt, Taylor, Prigge, Barnett, & Capecchi, 2000).
To determine the usefulness of our transgenic mice, we deter-
mined the effect of Cre expression in the retina over a 10-month
period. Since a direct consequence of Müller cell death is photore-
ceptor degeneration, the retinal morphology and function was
examined in the VMD2-cre mice. We did not detect any signiﬁcant
morphological changes in the mice (Fig. 6A). In addition, the scoto-
pic and photopic ERG analysis showed that these transgenic mice
had normal photoreceptor function (Fig. 6B and C). These results
suggest that Cre expression did not cause any detectable change
in retinal integrity in VMD2-cre mice, and thus the mice can be
used for gene function studies.
4. Discussion
To generate inducible RPE-speciﬁc cre mice, we recently used a
3.0-kb human VMD2 promoter to control a binary system that ex-
pressed tetracycline-inducible Cre recombinase (Le et al., 2008),
and identiﬁed a mouse line that had relatively strong Cre activity
in Müller cells during retinal development. Although the inducible
system in this VMD2-cremouse line was not tightly controlled and
the inducibility was less then onefold (Fig. 2A), an inherited prob-
lem of the tetracycline-inducible gene expression technology, this
mouse line offers an option for Cre/lox-based conditional gene
expression in retinal Müller cells. The efﬁciency of Cre-mediated
recombination at gp130 locus in Müller cells is 52%, which is com-
parable to the efﬁciency in two of our published studies (Rajala,
Tanito, Le, Kahn, & Rajala, 2008; Zheng, Anderson, Agbaga, Rucker,
& Le, 2006). This is not unexpected since conditional gene knock-
out studies usually have less than 100% efﬁciency of Cre-mediated
recombination. With approximately 50% of Müller cells undergoing
Cre-mediated recombination, this transgenic mouse line is ideal for
generating genetic mosaics, a widely used method to investigate
cell lineages, patterns of growth, and gene function, and to deal
with the challenge in phenotypic analysis of mice generated with
an all-or-none genetic approach (Collinson, Hill, & West, 2004).Fig. 5. Quantitative analysis of Cre-mediated recombination at gp130 locus in Müller cel
gp130, in response to leukemia inhibitory factor (LIF). (A–E) Single slice (0.5 lm) confoc
(A–C) and VMD2-cre+/gp130f/f mice (D–F). GS: glutamate synthetase. Scale bar: 25 lm.
errors. : p < 0.001 in t-test. Activation of STAT3 (pSTAT3) was detected by IHC 30 m
VMD2-cre/gp130f/f mice (A and C) in response to LIF, STAT3 was not activated in 5
Cre-mediated recombination occurred in 52.1% of Müller cells at gp130 locus.Of the 10 VMD2-cre lines we have generated, ﬁve demonstrated
Cre-activated b-gal reporter expression in retinal Müller cells (data
not shown). This result was surprising as the VMD2 promoter was
expected to drive Cre expression in the RPE. Expression of our
transgenes in retinal Müller cells is perhaps a characteristic of tran-
sient VMD2 promoter activity in retinal progenitor cells. This
expression pattern is seemingly contradictory to previous ﬁndings
that VMD2 expression was localized to the RPE (Bakall et al., 2003;
Esumi, Oshima, Li, Campochiaro, & Zack, 2004; Marquardt et al.,
1998; Petrukhin et al., 1998), However, we cannot exclude tran-
sient transcription of VMD2 in non-RPE lineage since the cell-spe-
ciﬁc expression pattern of VMD2 promoter during embryonic
development was not the focus of these earlier studies. To our
knowledge, only one previous study dealt with embryonic expres-
sion of bestrophin, which demonstrated the expression of its
mRNA in the eye at embryonic day 15 and there was no informa-
tion regarding tissue-speciﬁc expression (Bakall et al., 2003). It is
also important to point out two caveats of our study that prevent
current mice from being sufﬁcient to deﬁne VMD2 expression in
retinal progenitor cells deﬁnitively. The ﬁrst caveat is that the
VMD2 promoter used in these transgenic animals may not contain
all control elements necessary for identical expression patterns of
the endogenous gene. The second caveat is that our expression sys-
tem is a two transgene system. The unexpected expression pattern
may reﬂect the use of this binary system, in which the transgenes
are interacting to direct gene expression. Since Cre-mediated exci-
sion is not usually reversible, a transient expression of our trans-
genes in development will result in permanent removal of loxP
ﬂanked DNA. Therefore, regardless of the reasons behind the unex-
pected expression pattern, we deﬁnitely show that Cre activity is
detected in the retina before E15 in the transgenic line described.
Since we did not observe signiﬁcant difference in Cre-activated
b-gal activity between inductions from E15 to birth or P1 to P5,
as judged by b-gal staining assay (data not shown), the VMD2 pro-
moter is likely transiently active in progenitor cells, including
those leading to Müller cells. However, we cannot completely rule
out a possibility of very low level of Cre expression in the Müller
cells of this mouse line after birth.
In this VMD2-cre mouse, we observed near absence of Cre func-
tion in the RPE (Fig. 3). Since the presence of RPE-speciﬁc Cre func-
tion in another VMD2-cre mouse line derived from identical
transgenes (Le et al., 2008), a lack of RPE-speciﬁc expression in this
mouse line is probably due to a positional effect that is common tols by detecting phosphorylated STAT3 (pSTAT3), an activated downstream target of
al microscopic images of pSTAT3 in inner nuclear layer of VMD2-cre/gp130f/f mice
G: Frequency of Cre-mediated recombination in Müller cells. Error bars: standard
in after LIF injection. While LIF induced activation of STAT3 in all Müller cells in
2.1% of Müller cells in VMD2-cre+/gp130f/f (arrowheads in D–F), suggesting that
Fig. 6. Retinal morphology and function of 10-month-old VMD2-cremice. (A) Representative H&E-stained retinal sections of transgenic (TG) and wild-type (WT) mice. Outer
nuclear layer (ONL) and inner nuclear layer (INL) are labeled. Scale bar equal to 50 lm. (B and C) Scotopic and photopic ERG amplitudes. Flash intensity was 138 cd  s/m2 for
scotopic ERG and 79 cd  s/m2 photopic ERG. Error bars represent standard errors. Statistical analysis (t-test) showed that p-values for all waves were >0.05. At least eight
mice were included in each group. No signiﬁcant change in retinal morphology and function was detected in the VMD2-cre mice.
620 Y. Ueki et al. / Vision Research 49 (2009) 615–621transgenics (Jaenisch, 1988). In this study, we also observed Cre
activity in a subset of un-identiﬁed neurons in inner nuclear layer
(INL) and some photoreceptor cells (Fig. 4). This result may be a
consequence of Cre function in their progenitor cells during
embryonic development. In the VMD2-cre+/gp130f/f mice, less than
5% of rods lost STAT3 activation (data not shown), suggesting that
most photoreceptors retained at least one copy of gp130. No other
neural population in the retina lost a gp130 response. However, in
the single hit b-gal reporter assay, we did observe b-gal expression
in other neurons in the inner retina. End users of this mouse line
should be aware of this extra-Müller cell recombination activity
when designing their studies.
Acknowledgments
We thank W. Zheng and Y.W. Le for technical assistance, Dr. U.
Hochgeschwender of Microinjection Core Facility at the Oklahoma
Medical Research Foundation for the generation of the transgenic
mice, Drs. N. Esumi and D. Zack for providing human VMD2 pro-
moter DNA, and Dr. D. Sherry for helpful discussion. This study
was supported by NIH grants RR17703, EY16459, and EY12190,
ADA grant 1-06-RA-76, AHAF grant M2008-059, FFB grant BR-
CMM-0808-0453-UOK and unrestricted grants from Hope for
Vision and Research to Prevent Blindness.
References
Bakall, B., Marmorstein, L. Y., Hoppe, G., Peachey, N. S., Wadelius, C., & Marmorstein,
A. D. (2003). Expression and localization of bestrophin during normal mouse
development. Investigative Ophthalmology and Visual Science, 44, 3622–3628.
Betz, U. A., Bloch, W., van den Broek, M., Yoshida, K., Taga, T., Kishimoto, T., et al.
(1998). Postnatally induced inactivation of gp130 in mice results in
neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary
defects. Journal of Experimental Medicine, 188, 1955–1965.
Bringmann, A., Pannicke, T., Grosche, J., Francke, M., Wiedemann, P., Skatchkov, S.
N., et al. (2006). Muller cells in the healthy and diseased retina. Progress in
Retinal and Eye Research, 25, 397–424.
Collinson, J. M., Hill, R. E., & West, J. D. (2004). Analysis of mouse eye development
with chimeras and mosaics. International Journal of Developmental Biology, 48,
793–804.Esumi, N., Oshima, Y., Li, Y., Campochiaro, P. A., & Zack, D. J. (2004). Analysis of the
VMD2 promoter and implication of E-box binding factors in its regulation.
Journal of Biological Chemistry, 279, 19064–19073.
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O’Shea, K. S., et al. (1996).
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF
gene. Nature, 380, 439–442.
Gossen, M., Freundlieb, S., Bender, G., Muller, G., Hillen, W., & Bujard, H. (1995).
Transcriptional activation by tetracyclines in mammalian cells. Science, 268,
1766–1769.
Guo, F., Gopaul, D. N., & van Duyne, G. D. (1997). Structure of Cre recombinase
complexed with DNA in a site-speciﬁc recombination synapse. Nature, 389,
40–46.
Jaenisch, R. (1988). Transgenic animals. Science, 240, 1468–1474.
Jimeno, D., Feiner, L., Lillo, C., Teoﬁlo, K., Goldstein, L. S., Pierce, E. A., et al. (2006).
Analysis of kinesin-2 function in photoreceptor cells using synchronous Cre-
loxP knockout of Kif3a with RHO-Cre. Investigative Ophthalmology and Visual
Science, 47, 5039–5046.
Le, Y., Ash, J. D., Al-Ubaidi, M. R., Chen, Y., Ma, J., & Anderson, R. E. (2004). Targeted
expression of Cre recombinase to cone photoreceptors in transgenic mice.
Molecular Vision, 10, 1011–1018.
Le, Y., & Sauer, B. (2000). Conditional gene knockout using cre recombinase.Methods
in Molecular Biology, 136, 477–485.
Le, Y., Zheng, W., Rao, P., Zheng, L., Anderson, R. E., Esumi, N., et al. (2008). Inducible
expression of Cre recombinase in the retinal pigmented epithelium.
Investigative Ophthalmology and Visual Science, 49, 1248–1253.
Le, Y., Zheng, L., Zheng, W., Agbaga, M., Zhu, M., Ash, J. D., et al. (2006). Mouse opsin
promoter controlled expression of Cre recombinase in transgenic mice.
Molecular Vision, 12, 389–398.
Loonstra, A., Vooijs, M., Beverloo, H. B., Allak, B. A., van Drunen, E., Kanaar, R., et al.
(2001). Growth inhibition and DNA damage induced by Cre recombinase in
mammalian cells. Proceedings of the National Academy of Sciences of the United
States of America, 98, 9209–9214.
Marquardt, A., Stohr, H., Passmore, L. A., Kramer, F., Rivera, A., & Weber, B. H. (1998).
Mutations in a novel gene, VMD2, encoding a protein of unknown properties
cause juvenile-onset vitelliform macular dystrophy (Best’s disease). Human
Molecular Genetics, 7, 1517–1525.
Petrukhin, K., Koisti, M. J., Bakall, B., Li, W., Xie, G., Marknell, T., et al. (1998).
Identiﬁcation of the gene responsible for Best macular dystrophy. Nature
Genetics, 19, 241–247.
Quiambao, A. B., Peachey, N. S., Mangini, N. J., Rohlich, P., Hollyﬁeld, J. G., & al-
Ubaidi, M. R. (1997). A 221-bp fragment of the mouse opsin promoter directs
expression speciﬁcally to the rod photoreceptors of transgenic mice. Visual
Neuroscience, 14, 617–625.
Rajala, R. V., McClellan, M. E., Chan, M. D., Tsiokas, L., & Anderson, R. E. (2004).
Interaction of the retinal insulin receptor beta-subunit with the p85 subunit of
phosphoinositide 3-kinase. Biochemistry, 43, 5637–5650.
Rajala, A., Tanito, M., Le, Y. Z., Kahn, C. R., & Rajala, R. V. (2008). Loss of
neuroprotective survival signal in mice lacking insulin receptor gene in rod
photoreceptor cells. Journal of Biological Chemistry, 283, 19781–19792.
Y. Ueki et al. / Vision Research 49 (2009) 615–621 621Rucker, E. B., 3rd, Dierisseau, P., Wagner, K. U., Garrett, L., Wynshaw-Boris, A., Flaws,
J. A., et al. (2000). Bcl-x and Bax regulate mouse primordial germ cell survival
and apoptosis during embryogenesis. Molecular Endocrinology, 14, 1038–1052.
Sauer, B., & Henderson, N. (1988). Site-speciﬁc DNA recombination in mammalian
cells by the Cre recombinase of bacteriophage P1. Proceedings of the National
Academy of Sciences of the United States of America, 85, 5166–5170.
Schmidt, E. E., Taylor, D. S., Prigge, J. R., Barnett, S., & Capecchi, M. R. (2000).
Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse
spermatids. Proceedings of the National Academy of Sciences of the United States of
America, 97, 13702–13707.
Soriano, P. (1999). Generalized lacZ expression with the ROSA26 Cre reporter strain.
Nature Genetics, 21, 70–71.Ueki, Y., Wang, J., Chollangi, S., & Ash, J. D. (2008). STAT3 activation in
photoreceptors by leukemia inhibitory factor is associated with protection
from light damage. Journal of Neurochemistry, 105, 784–796.
Xu, X., Quiambao, A. B., Roveri, L., Pardue, M. T., Marx, J. L., Rohlich, P., et al. (2000).
Degeneration of cone photoreceptors induced by expression of the Mas1
protooncogene. Experimental Neurology, 163, 207–219.
Yao, L., Yokota, T., Xia, L., Kincade, P. W., & McEver, R. P. (2005). Bone marrow
dysfunction in mice lacking the cytokine receptor gp130 in endothelial cells.
Blood, 106, 4093–4101.
Zheng, L., Anderson, R. E., Agbaga, M. P., Rucker, E. B., 3rd, & Le, Y. Z. (2006). Loss of
BCL-XL in rod photoreceptors: Increased susceptibility to bright light stress.
Investigative Ophthalmology and Visual Science, 47, 5583–5589.
